Radius Recycling Inc. (RDUS) is an Industrial Specialties company listed on NASDAQ. In the last 30 days Quantisnow tracked 1 wire item for RDUS, including 1 leadership change. The most recent was published Nov 4, 2026.

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

News · 26 weeks1+100%
2026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 12026-11-08: 02026-11-15: 0
2026-05-242026-11-15
Mix190d
  • Leadership1(100%)
Activity · 52 weeks11 active day
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

RDUS FAQ

7 questions
  • What does Radius Recycling Inc. do?
    Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical...
  • What is the latest news on RDUS?
    In the last 30 days Quantisnow tracked 1 wire item for RDUS: 1 leadership change. The most recent was published on November 4, 2026.
  • Where does RDUS stock trade?
    Radius Recycling Inc. (RDUS) is listed on NASDAQ.
  • What sector and industry is RDUS in?
    Radius Recycling Inc. operates in the Consumer Discretionary sector, Industrial Specialties industry.
  • What are analysts saying about RDUS?
    Across the last 8 analyst actions on Radius Recycling Inc., there were 2 upgrades and 3 downgrades. The most recent action was from Goldman: Neutral with a $22.00 price target on 2024-12-02. Recent price targets range from $7.00 to $22.00.
  • What companies are similar to RDUS?
    Notable peers in the same industry include ZBH (Zimmer Biomet Holdings Inc.), STE (STERIS plc (Ireland)), ALGN (Align Technology Inc.), EW (Edwards Lifesciences Corporation), ISRG (Intuitive Surgical Inc.). Compare RDUS side-by-side with any of them on Quantisnow.
  • How can I track RDUS on Quantisnow?
    Quantisnow aggregates Radius Recycling Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RDUS to receive live email and push alerts on every new disclosure.